These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16508961)

  • 1. Reducing CDK4/6-p16(INK4a) interface. Computational alanine scanning of a peptide bound to CDK6 protein.
    Villacañas O; Rubio-Martinez J
    Proteins; 2006 Jun; 63(4):797-810. PubMed ID: 16508961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4a) Peptide mimetics identified via virtual screening.
    Klein MA; Mayo KH; Kratzke RA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):403-5. PubMed ID: 19914831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
    Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP
    Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
    Villacañas O; Pérez JJ; Rubio-Martínez J
    J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6.
    Jones R; Ruas M; Gregory F; Moulin S; Delia D; Manoukian S; Rowe J; Brookes S; Peters G
    Cancer Res; 2007 Oct; 67(19):9134-41. PubMed ID: 17909018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico analysis of structural and functional consequences in p16INK4A by deleterious nsSNPs associated CDKN2A gene in malignant melanoma.
    Rajasekaran R; Priya Doss CG; Sudandiradoss C; Ramanathan K; Sethumadhavan R
    Biochimie; 2008 Oct; 90(10):1523-9. PubMed ID: 18573309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
    Khuntawee W; Rungrotmongkol T; Hannongbua S
    J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal domain of p16(INK4a) is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fibrosarcoma cells.
    Fahham N; Sardari S; Ostad SN; Vaziri B; Ghahremani MH
    J Cell Biochem; 2010 Dec; 111(6):1598-606. PubMed ID: 21053367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfolding transition state and intermediates of the tumor suppressor p16INK4a investigated by molecular dynamics simulations.
    Interlandi G; Settanni G; Caflisch A
    Proteins; 2006 Jul; 64(1):178-92. PubMed ID: 16596641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex.
    Zoete V; Michielin O
    Proteins; 2007 Jun; 67(4):1026-47. PubMed ID: 17377991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of p16ink4a-binding proteins.
    Souza-Rodrígues E; Estanyol JM; Friedrich-Heineken E; Olmedo E; Vera J; Canela N; Brun S; Agell N; Hübscher U; Bachs O; Jaumot M
    Proteomics; 2007 Nov; 7(22):4102-11. PubMed ID: 17955473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
    Mahajan A; Guo Y; Yuan C; Weghorst CM; Tsai MD; Li J
    J Mol Biol; 2007 Nov; 373(4):990-1005. PubMed ID: 17881001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P; Agarwal P; Bird RC
    J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the stabilization of INK4 tumor suppressor 3D structure evaluated by quantum chemical and molecular mechanics calculations corresponds well with experimental results: interplay of association enthalpy, entropy, and solvation effects.
    Otyepka M; Sklenovský P; Horinek D; Kubar T; Hobza P
    J Phys Chem B; 2006 Mar; 110(9):4423-9. PubMed ID: 16509744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of a hyperstable p16INK4a that restores Cdk4 binding activity when combined with oncogenic mutations.
    Cammett TJ; Luo L; Peng ZY
    J Mol Biol; 2003 Mar; 327(1):285-97. PubMed ID: 12614625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure and site 1 binding energetics of human placental lactogen.
    Walsh ST; Kossiakoff AA
    J Mol Biol; 2006 May; 358(3):773-84. PubMed ID: 16546209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo simulations of the peptide recognition at the consensus binding site of the constant fragment of human immunoglobulin G: the energy landscape analysis of a hot spot at the intermolecular interface.
    Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Freer ST; Rose PW
    Proteins; 2002 Aug; 48(3):539-57. PubMed ID: 12112677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6.
    Cho YS; Borland M; Brain C; Chen CH; Cheng H; Chopra R; Chung K; Groarke J; He G; Hou Y; Kim S; Kovats S; Lu Y; O'Reilly M; Shen J; Smith T; Trakshel G; Vögtle M; Xu M; Xu M; Sung MJ
    J Med Chem; 2010 Nov; 53(22):7938-57. PubMed ID: 21038853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating receptor flexibility in the molecular design of protein interfaces.
    Li L; Liang S; Pilcher MM; Meroueh SO
    Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.